rs34214448

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000269.3(NME1):​c.-5+989G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.386 in 152,028 control chromosomes in the GnomAD database, including 11,330 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11330 hom., cov: 32)

Consequence

NME1
NM_000269.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00500

Publications

16 publications found
Variant links:
Genes affected
NME1 (HGNC:7849): (NME/NM23 nucleoside diphosphate kinase 1) This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Jul 2008]
NME1-NME2 (HGNC:33531): (NME1-NME2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring NME1 and NME2 genes. The significance of this read-through transcription and the function of the resulting protein product have not yet been determined. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000269.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000269.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NME1
NM_000269.3
MANE Select
c.-5+989G>T
intron
N/ANP_000260.1P15531-1
NME1-NME2
NM_001018136.3
c.-5+989G>T
intron
N/ANP_001018146.1
NME1
NM_198175.1
c.71+207G>T
intron
N/ANP_937818.1P15531-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NME1
ENST00000393196.8
TSL:1 MANE Select
c.-5+989G>T
intron
N/AENSP00000376892.3P15531-1
NME1-NME2
ENST00000393193.6
TSL:2
c.-5+989G>T
intron
N/AENSP00000376889.2
NME1
ENST00000336097.7
TSL:1
c.71+207G>T
intron
N/AENSP00000337060.3P15531-2

Frequencies

GnomAD3 genomes
AF:
0.386
AC:
58684
AN:
151912
Hom.:
11316
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.375
Gnomad AMI
AF:
0.412
Gnomad AMR
AF:
0.407
Gnomad ASJ
AF:
0.408
Gnomad EAS
AF:
0.378
Gnomad SAS
AF:
0.306
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.402
Gnomad NFE
AF:
0.397
Gnomad OTH
AF:
0.396
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.386
AC:
58736
AN:
152028
Hom.:
11330
Cov.:
32
AF XY:
0.382
AC XY:
28406
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.375
AC:
15552
AN:
41444
American (AMR)
AF:
0.406
AC:
6201
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
1415
AN:
3466
East Asian (EAS)
AF:
0.378
AC:
1959
AN:
5180
South Asian (SAS)
AF:
0.307
AC:
1479
AN:
4824
European-Finnish (FIN)
AF:
0.364
AC:
3843
AN:
10568
Middle Eastern (MID)
AF:
0.394
AC:
115
AN:
292
European-Non Finnish (NFE)
AF:
0.397
AC:
26953
AN:
67962
Other (OTH)
AF:
0.400
AC:
845
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1866
3731
5597
7462
9328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.397
Hom.:
1436
Bravo
AF:
0.391
Asia WGS
AF:
0.359
AC:
1247
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
2.6
DANN
Benign
0.25
PhyloP100
-0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs34214448;
hg19: chr17-49232012;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.